Related by context. All words. (Click for frequent words.) 78 Shigamabs ® 74 Shigamabs R 65 OraTest R 65 Pruvel 64 Shigatoxin producing E. coli 64 vaginally administered lidocaine 64 Surfaxin LS 64 XP# XP# 64 Phase lll 63 Allovectin 7 r 63 inhaled AAT 63 Altastaph 63 apricitabine ATC 63 faropenem 63 HepeX B 62 ChimeriVax JE 62 GLP toxicology studies 62 Increlex TM 62 G#DT 62 histamine dihydrochloride 62 daptomycin 62 bardoxolone 62 telaprevir VX 62 Urocidin TM 62 VaxImmune 62 Hedgehog antagonist 62 Dalbavancin 62 DDP# 61 Panzem R NCD 61 SinuNase ™ 61 T Pred 61 Factor VIIa 61 tramiprosate ALZHEMED TM 61 PrevOnco ™ 61 LymphoStat B TM 61 MAXY alpha 61 balsalazide tablet 61 celgosivir 61 Kyowa Kirin 61 Valortim TM 61 EGRIFTA TM 61 Phase Ib study 61 tiapamil 61 non nucleoside HCV 61 BLA filing 61 TBC# 61 Ramoplanin 61 Panzem R 61 DIFICID ™ 61 miconazole MBT 61 Anidulafungin 61 AzaSite TM 61 AzaSite Xtra 61 hoFH 61 pradefovir 61 incyclinide 61 UPLYSO 61 Cellegesic 61 Panzem ® 61 CIP TRAMADOL ER 60 Civacir 60 photodisinfection 60 SinuNase TM 60 acetonide FA 60 HuMax CD4 60 Somatuline R Depot 60 CholeraGarde R 60 Puricase PEG uricase 60 Ceragenin 60 Rhein Biotech GmbH 60 Evoltra ® 60 AzaSite Plus 60 CRMD# 60 RIGScan CR 60 Vaxfectin R 60 Phase Ib II 60 MOVIPREP R 60 VivaGel ™ 60 Q#IR 60 Caleco 60 Nabi HB Intravenous 60 Rotarix R 60 EV# vaccine 60 Shire BioChem Inc. 60 vidofludimus 60 OvaRex R 60 Hepatitis C HCV 60 Japanese Encephalitis Vaccine 60 JAK inhibitor 60 cGMP manufacture 60 APTIMA HPV assay 60 Somatuline R Autogel R 60 Urocidin 60 XL# XL# 60 Faropenem 60 Fodosine 60 PGL# 60 Thiovir 60 tramiprosate Alzhemed TM 60 MVA BN R 60 ulimorelin 60 successfully commercialize Iluvien 60 Restanza TM 60 Protexia ® 60 CCR5 mAb 60 TransVax TM 60 RELOVAIR ™ 60 AcryMed Incorporated 60 SYCREST 60 Potelligent Technology 60 Phase IIb clinical trials 60 tolevamer 60 opioid bowel dysfunction 60 FOLOTYN ® 60 trastuzumab DM1 T DM1 60 FACTIVE tablets 59 Proquin XR 59 Aerosurf 59 nosocomial pneumonia 59 reslizumab 59 Alferon N Injection 59 SEPET TM 59 nucleotide analog 59 Nanobody R 59 HCD# [002] 59 personalized immunotherapy 59 BrachySil TM 59 SILENOR 59 IV Busulfex 59 Lipsovir ® 59 MAA submission 59 investigational hepatitis B 59 MAXY VII 59 Bioral Amphotericin B 59 Trovax 59 herpetic keratitis 59 miconazole Lauriad ® 59 Aroplatin 59 acyclovir Lauriad R 59 Soliris eculizumab 59 Hyphanox 59 including eniluracil ADH 59 TYZEKA 59 Ecallantide 59 CytoFab 59 HepaGam B 59 Harry Palmin President 59 ITAX 59 TRANSDUR Bupivacaine 59 Chimigen TM 59 NovaBay Aganocide compounds 59 sNDAs 59 subsidiaries visit http:/www.apricusbio.com 59 PDE4 inhibitor 59 NeutroSpec TM 59 Immunotherapeutic 59 Spiegelmer ® 59 PDE# inhibitors 59 Allovectin 7 R 59 elotuzumab 59 Stimuvax R 59 2 inhibitor CYT# 59 JAK2 inhibitor 59 HuMax TAC 59 Flutiform ™ 59 SynCon 59 RhuDex TM 59 porcine derived 59 Hedgehog pathway inhibitor 59 Loramyc ™ 59 FDA Approvable Letter 59 cardio renal 59 Alferon N 59 EHT AGN 59 Tyzeka Sebivo 59 RenaZorb 59 DEB# 59 HIV coinfected 59 photodisinfection technology 59 Targeted Chemotherapy 59 torezolid phosphate 59 BACcel 59 Androxal TM 59 Multiple Ascending Dose 59 rhFVIIa 59 drug ISA# 59 DPX Survivac 59 romazarit 59 hypoxia activated prodrug 59 ZFP Therapeutics 59 INACTINE TM 59 CMV vaccine 59 Cx# [002] 59 BENLYSTA ® 59 lucinactant 59 novel therapeutic antibodies 58 Ampligen r 58 HspE7 58 anti CD3 monoclonal 58 micafungin 58 Phase 2a clinical trials 58 Onalta ™ 58 GRNVAC1 58 Telatinib 58 Stavzor TM 58 P#X# antagonist 58 prokinetic agent 58 PHX# 58 OHR/AVR# 58 orally administered inhibitor 58 BAL# [002] 58 Alequel TM 58 sJIA 58 Reports Preclinical Data 58 Alvesco R 58 IV APAP 58 GVAX ® 58 SPRYCEL ® 58 HDL Selective Delipidation 58 trivalent influenza vaccine 58 Initiates Clinical 58 PANVAC VF 58 ILUVIEN ® 58 Dermylex TM 58 Zemiva TM 58 XL# anticancer compounds 58 PREOS R 58 HepeX B TM 58 Japanese Encephalitis vaccine 58 Saforis 58 vaginal candidiasis 58 ChronVac C R 58 Alzhemed TM 58 isavuconazole 58 hypersensitivity allergic reactions 58 Kosan dependence 58 LymphoStat B belimumab 58 pneumococcal conjugated vaccine 58 volociximab 58 Aganocide 58 Vascular Wrap TM 58 REMINYL ® 58 PREGNANT Study 58 budesonide foam 58 AMPK activators 58 TELINTRA 58 PDX pralatrexate 58 Therinject 58 Amoxicillin PULSYS Phase III 58 Iluvien TM 58 MyVax ® 58 ganaxolone 58 Ultrafast Insulin 58 Zenvia ™ 58 TKB# 58 CDAD Clostridium difficile 58 EVIZON TM squalamine lactate 58 RhuDex ® 58 valtorcitabine 58 forodesine 58 liprotamase 58 FACTIVE R gemifloxacin 58 R#/MEM 58 Omigard 58 trivalent seasonal influenza 58 HuMax HepC TM 58 Biologic License Application BLA 58 acyclovir Lauriad ® 58 POSIDUR TM 58 ATryn ® 58 MGN# 58 Tasimelteon 58 Vancocin ® 58 oncolytic virus therapies 58 TRISENOX ® 58 TransVax ™ 58 Glypromate 58 immunotherapeutic vaccine 58 CIP ISOTRETINOIN 58 Virulizin R 58 TransVax tm 58 ketolide antibiotic 58 oxypurinol 58 Troxatyl TM 58 Insegia 58 phase Ib clinical 58 Syntonix 58 CAMPATH 58 Gentamicin Surgical Implant 58 Flutiform TM 58 Optiquel ™ 58 Xanafide 58 Aphthasol R 58 Infergen R 58 HuLuc# 58 Virulizin 58 LEP ETU 58 STEDESA 58 Medidur FA 58 anti CD# antibodies 58 elbion 58 Etubics 58 Prodarsan R 58 alemtuzumab MS 58 treat chronic sinusitis 58 hepatitis C HCV 58 StemEx R 58 Zhejiang Hisun 58 Ketotransdel 58 beta lactamase inhibitor 58 Cinryze ™ 58 Oncaspar 58 inflammatory autoimmune diseases 57 Phase Ib clinical 57 cystinosis patients 57 EP #R 57 sterile lidocaine patch 57 Cutanea Life Sciences 57 Cloretazine 57 Generx TM 57 Nasdaq ACHN 57 DOS# 57 ENTOCORT EC 57 im peramivir 57 Loramyc TM 57 mertansine 57 ZADAXIN ® 57 Dyloject TM 57 Bionutrics 57 OMNARIS Nasal Spray 57 EVIZON TM 57 Xcytrin R 57 Berinert 57 LibiGel ® 57 vaginal lidocaine 57 outlicensing 57 plasmid DNA vaccine 57 Lovaza TM 57 diarrhea predominant irritable 57 injectable formulations 57 MONOVISC 57 Amoxicillin PULSYS 57 Bicifadine 57 oral prodrug 57 Rescula 57 Canvaxin TM 57 patented Bioral 57 VISICOL R 57 Phase IIIb clinical 57 SYGNIS 57 synDNA TM 57 LGLS 57 Cleviprex TM clevidipine 57 Nascobal Nasal Spray 57 NM# [001] 57 PRECISE trial 57 deforolimus 57 Poly ICR 57 PEG interferon 57 recombinant biopharmaceutical 57 ATIR 57 Dacogen injection 57 Anturol TM 57 GLASSIA 57 FluCide 57 cicletanine 57 initiated Phase Ib 57 IIa trials 57 ularitide 57 Acute Radiation Syndrome ARS 57 anti infective treatments 57 biologic therapeutics 57 lomitapide 57 Voraxaze 57 inhaled liposomal ciprofloxacin 57 Cytolin 57 Crucell PER.C6 57 Actimmune ® 57 Entereg TM 57 Exelixis compounds 57 TaiGen 57 ARIKACE ™ 57 catheter occlusion 57 Veronate 57 CDP# 57 Heap Leach Project 57 HCV polymerase 57 Hectorol R 57 Submits Response 57 Viramidine 57 investigational humanized monoclonal antibody 57 Fibrillex TM 57 IND submission 57 AMPAKINE CX# 57 novel emulsion formulation 57 Archexin 57 faropenem medoxomil 57 Cumulase 57 AMD# [002] 57 Prednisporin 57 cannabinor 57 IoGen 57 LE SN# 57 hepatitis B immune globulin 57 sodium thiosulfate STS 57 Phase #/#a 57 ara C 57 Twinrix 57 candidate Ramoplanin 57 Prestara 57 MorphoSys proprietary 57 cat dander allergy 57 stated Michelle Berrey 57 novel histone deacetylase 57 TLR antagonists 57 EGRIFTA ™ 57 fluconazole resistant 57 unoprostone isopropyl 57 thetreatment 57 CytoFabTM 57 terlipressin 57 Initiates Phase II 57 Cintredekin Besudotox 57 Inovocox TM 57 Fabry Disease 57 Pennsaid Plus 57 Stressgen 57 PROVENGE ® 57 TP# CETi 1 57 Elan NanoCrystal 57 GLP1 INT TM 57 oral antiviral 57 Neo Kidney Augment 57 GPR# agonist 57 OMAPRO 57 OLpur TM MD 57 PLK1 SNALP 57 Amgen Neulasta R 57 NP2 Enkephalin 57 Pafuramidine 57 preclinical toxicology 57 CryoSeal 57 ONCONASE R 57 Personalized Immunotherapy 57 OTCBB PYTO 57 dalbavancin 57 Allovectin 7 57 REPLAGAL 57 solithromycin 57 Solazed 57 Zirgan 57 gastrointestinal disorders ATI 57 Solasia 57 MYLOTARG 57 NOD SCID mice 57 sitaxsentan 57 miconazole Lauriad R 57 Aloxi injection 57 Lenocta TM 57 Phase 1b clinical 57 Soliris TM eculizumab 57 forodesine hydrochloride 57 BRILINTA 57 Bioaccelerate compounds under 57 immatics 57 IMA# 57 FluINsure 57 Phase #b/#a clinical 57 HuCAL antibodies 57 BEMA Granisetron 57 HYVISC R 57 menadione 57 OPi 57 BrachySil ™ 57 ACTILON 57 BrachySil 57 Entereg R 57 Hedgehog Pathway Inhibitor 57 JAK2 Inhibitor 57 Thelin tm 57 Bacteremia 57 bioFILM PA TM 57 omacetaxine mepesuccinate 57 ESTRASORB 57 tezampanel NGX# 57 Taiho Pharmaceutical 57 Onconase 57 cinacalcet HCl 57 EBx ® 57 Dextofisopam 57 OvaRex ® MAb 57 JZP 57 InterfeRx 57 Troxatyl 56 Prednisporin TM 56 confirmatory Phase III 56 Acetavance TM intravenous acetaminophen 56 topical ophthalmic 56 Emezine 56 Manja Bouman CEO 56 MAGE A3 ASCI 56 Exelbine 56 ETEC vaccine 56 HEPLISAV ™ 56 Targretin capsules 56 AN# novel 56 recombinant protein therapeutics 56 Cloretazine ® 56 interferon gamma 1b 56 Phase #b/#a 56 CD# CEA 56 Cethromycin 56 glucokinase activator 56 SNT MC# 56 Oracea TM 56 PLAVIX ® 56 RSD# oral 56 Copegus ribavirin 56 Oasmia 56 investigational monoclonal antibody 56 Plenaxis R 56 TYGACIL 56 Anadis 56 molecular imaging radiopharmaceutical 56 severe hypercholesterolemia 56 StaphVAX R 56 Plicera 56 PER.C6 r 56 treatment naive genotype 56 opioid induced bowel dysfunction 56 recurrent herpes labialis 56 TCAD therapy 56 Alnylam #x# 56 Lauren Silvernail 56 ARRY # 56 carcinoid syndrome 56 Intercell vaccine 56 IMVAMUNE 56 PrevOnco 56 isoform selective 56 PREVNAR 56 Phenoptin 56 Omigard TM 56 JAK1 56 Glassia 56 Stavzor ™ 56 Ceflatonin R 56 R5 tropic 56 VP# [004] 56 PDL# 56 NeuroSTAT ® 56 naronapride 56 CEQ# 56 Ascend Therapeutics 56 Pivotal Phase III 56 Phase 1a clinical 56 rPA anthrax vaccine 56 Lung Rx 56 Extina 56 Zemiva ™ 56 Submits NDA 56 topical anti infective 56 casopitant 56 alemtuzumab Campath 56 TKM ApoB 56 REP# 56 alvespimycin 56 ruxolitinib 56 Mesafem 56 polycythemia vera essential thrombocythemia 56 LEVADEX ™ 56 synthetic retinoid 56 RELISTOR ® 56 NASDAQ PGNX 56 lumiliximab 56 candidate CRLX# 56 NEUMUNE 56 Glufosfamide 56 MEND CABG II 56 sumatriptan DosePro 56 Urokinase 56 Phase IIa trials 56 phase IIb clinical 56 Evoltra TM 56 Besivance 56 Stanate R 56 MAXY G# 56 oral salmon calcitonin 56 FOR FURTHER INFORMATION ABOUT 56 Neuradiab 56 ATL# [002] 56 Prochieve R 56 Cimzia TM 56 initiate Phase IIa 56 Zenapax 56 phase IIa 56 Rotarix ® 56 Aurexis 56 SILENOR TM 56 Celgosivir 56 AdVac 56 Phase Ib IIa 56 XmAb 56 ophthalmic diseases 56 rhMBL 56 oral PTH 56 initiate multicenter 56 XL# XL# XL# XL# 56 Rhucin ® recombinant 56 THALOMID 56 GVAX R 56 LUCASSIN 56 Aryplase 56 FluBlok 56 Hepavax Gene ® 56 Oncosphere 56 OMNARIS HFA 56 GALNS 56 EnzymeRx 56 Exelixis XL# 56 EpiCeram 56 Augment Injectable 56 Ceplene histamine dihydrochloride 56 elvucitabine 56 RIGScan ™ 56 Prulifloxacin 56 LB# [003] 56 tuberculosis hepatitis B 56 HCV polymerase inhibitor 56 Nicotine Conjugate Vaccine 56 Kuvan TM sapropterin 56 LigoCyte 56 Nuvion 56 proprietary radiolabeled monoclonal 56 iii Cubist 56 MVA HPV IL2 56 Protexia R 56 HCV RNA polymerase 56 Uvidem 56 LEUKINE 56 Lixivaptan 56 zanolimumab 56 TOCOSOL Paclitaxel 56 ATL/TV# 56 PentaStaph 56 Elevess 56 Aganocide ® 56 subunit vaccines 56 Oglemilast 56 Gets FDA Clearance 56 intranasal insulin product 56 AERx iDMS 56 inhaled antibiotic 56 TRAIL receptor antibodies 56 rindopepimut 56 Tekturna Rasilez 56 ERYtech 56 Anavex #-# 56 Initiates Clinical Trial 56 Neovasc Reducer 56 Galenea 56 cMET inhibitor 56 JNJ Q2 56 Bayer HealthCare Onyx Pharmaceuticals 56 ACTCellerate 56 Submits Investigational 56 Æterna Zentaris 56 immunomodulatory therapy 56 hyperimmune products 56 oral methylnaltrexone 56 Arno Therapeutics 56 VivaGel ® 56 initiate Phase 1b 56 ASONEP TM 56 antibody MAb 56 Kepivance 56 USL# 56 inhalation toxicology 56 confirmatory clinical 56 eprodisate KIACTA TM 56 ALN PCS 56 muscarinic receptor agonist 56 Ibis T# Biosensor System 56 atacicept 56 Zemplar Capsules 56 Completes Patient Enrollment 56 Antibody Discovery 56 Orphan Drug designations 56 IND enabling 56 NeoVisc R 56 AQ4N 56 THR beta agonist 56 Selective Electrochemical Tumor Ablation 56 TransVax 56 Lymphoseek ® 56 ZEVALIN ® 56 nanoviricides 56 Initiate Clinical Trial 56 arsenic trioxide injection 56 valopicitabine NM# 56 Restanza 56 Protease Inhibitor 56 ceftazidime 56 LEVADEX TM 56 Phase IIa clinical trials 56 Phospha E 56 Camvia 56 BEMA TM Fentanyl 56 BLP# Liposome Vaccine 56 Ropren 56 Prosaptide 56 Acetavance TM 56 Unit Dose Budesonide 56 novel VDA molecule 56 ALN RSV program 56 Aurograb 56 Pseudomonas aeruginosa infections 56 NXL# 56 Alligator Bioscience AB 56 RECOTHROM R 56 drug GAP #B# 56 Crofelemer budesonide foam 56 Vitaxin 56 noninvasive prenatal tests 56 AMEVIVE 56 Myozyme ® alglucosidase 56 YONDELIS 56 recombinant FVIII 56 conjugate vaccines 56 MOZOBIL 56 ONTAK 56 factor VIIa 56 DermaVir Patch 56 BioMarck 56 AdVac R 56 incorporate CXA 56 2 methoxyestradiol 56 Squalamine 56 Orapred ODT 56 CONBRIZA 56 Mpex 56 STELARA TM 55 phase IIa clinical 55 Glybera R 55 nalbuphine ER 55 Allovectin 7 ® 55 BHT DNA 55 Nektar pulmonary 55 CINTREDEKIN BESUDOTOX 55 Quark Biotech 55 Phase 2b clinical trials 55 BeneFIX 55 Anturol ® 55 toenail onychomycosis 55 Sylvie Gregoire President 55 serogroup B 55 Lenocta 55 GERD migraine headaches 55 Nektar proprietary 55 BioGlue ® 55 severe dermatologic toxicities 55 RTP #i 55 Martin Nicklasson CEO 55 Relieva 55 novel L DOS# 55 generation purine nucleoside 55 Pegloticase 55 rhC1INH 55 Therapeutic Vaccine 55 Nipent R 55 Helinx technology 55 NUCRYST Pharmaceuticals 55 biodefense countermeasure 55 Clindesse TM 55 Multiferon R 55 Ceftaroline 55 Urocortin 2 55 Phase IIb trials 55 Enhanze 55 postoperative ileus POI 55 fibrotic disorders 55 EGS# 55 REGiMMUNE 55 MKC# MT 55 APEX PD 55 Staphylococcus aureus Polysaccharide Conjugate 55 EGFR HER2 55 Velac 55 Zeneus 55 kidney urologic 55 Initiates Enrollment 55 recombinant factor VIIa 55 Amigal 55 KIACTA ™ 55 forodesine HCl 55 ZEFTERA TM Zevtera TM 55 NEUGENE 55 Firdapse 55 Evotec Neurosciences 55 StemEx 55 prophylactic vaccines 55 initiate Phase 2b 55 valent pneumococcal conjugate vaccine 55 Vion Pharmaceuticals 55 zileuton IV 55 sirtuin modulators 55 phase IIb III 55 humanized monoclonal 55 ZEGERID Capsules 55 AMEX ONI 55 intravenous AAT 55 TLK# 55 Patrys 55 brivaracetam 55 Alocrest 55 oral picoplatin 55 SILENOR ™ 55 maribavir 55 ONCASPAR 55 Quinvaxem R 55 sargramostim 55 XL# SAR# 55 ALTROPANE R 55 NXC 55 Chemical Entity NCE 55 CancerVax Corporation 55 Firazyr 55 PHASE III 55 rxRNA 55 VIBEX MTX 55 Sebivo 55 Pyridorin 55 Virium 55 Junovan 55 Behcet uveitis 55 anti infective ophthalmic 55 Trofex 55 vapreotide acetate 55 recombinant Factor VIIa 55 VLP vaccine 55 dextromethorphan quinidine 55 topical anti infectives 55 phase III isavuconazole 55 pain palliation 55 RAPTIVA 55 LentiVector technology 55 research anddevelopment 55 novel oral anticoagulant 55 trodusquemine 55 OTC BB NNVC.OB 55 NTDDS 55 Aegera 55 Immuron 55 ATPace TM 55 INS# [001] 55 Hybridon 55 ENZON 55 EndoTAG TM -1 55 lintuzumab SGN 55 DermTech International 55 NeoVisc 55 Sanvar R 55 Adenosine Therapeutics 55 oral beclomethasone dipropionate 55 Phase #b/#a trial 55 markets HP Acthar 55 GATTEX TM 55 Levulan ® PDT 55 Fentanyl TAIFUN R 55 Dose Ranging Study 55 ROTATEQ 55 NADiA ProsVue 55 candidate deforolimus 55 Cutanea 55 Cyplasin 55 talactoferrin 55 ocular formulation 55 Viral Immunotherapy platform 55 commercialize AzaSite 55 Pliaglis 55 rhLF 55 midstage trials 55 fusion enhancers 55 beta 1a 55 dirucotide MBP# 55 HGS# 55 MethyPatch 55 Difimicin 55 Progenta TM 55 antiinfective 55 Begin Clinical Trials 55 biotherapeutic drugs 55 AE# vaccine 55 Viprinex TM 55 Zensana TM 55 Liprotamase 55 CLIA waiver 55 TASKi3 55 Viralytics 55 ATL# [001] 55 CUBICIN 55 selective GR 55 samalizumab 55 RhuDex 55 enterococcal 55 ENTB 55 Argatroban 55 crofelemer 55 Phase Ib 55 Zemiva TM Trofex TM 55 Azilect ® 55 TRISENOX 55 preclinical efficacy 55 ibudilast 55 PEP# [003] 55 ASONEP 55 prophylactic vaccine 55 phase IIb trial 55 refractory chronic lymphocytic 55 Exherin TM 55 HCV antiviral 55 KRYSTEXXA TM pegloticase 55 HCV protease inhibitor 55 Nasdaq IDIX biopharmaceutical 55 RNAi therapeutic targeting 55 rPA vaccine candidate 55 ABILIFY ® 55 BLA submission 55 transgenically produced product 55 SMT C# 55 Neutrolin ® 55 CCX# 55 immuno inflammatory diseases 55 BioDelivery Sciences Announces 55 pafuramidine 55 Dynogen 55 methylnaltrexone bromide 55 rALLy clinical trial 55 product platforms AZX# 55 Somatuline Depot 55 Topical Interferon Alpha 2b 55 Aflunov 55 biodefense pathogens 55 Telbivudine 55 siRNA therapeutics 55 Dr. Halvor Jaeger 55 Initiates Phase 2b 55 Femprox 55 mSEPT9 biomarker 55 Gamunex C 55 Simulect 55 FlexStent ® 55 VLP vaccine candidate 55 Loramyc 55 systemic immunosuppressive drugs 55 Files Investigational 55 MKC# MKC# PP 55 PEG PAL 55 HEPLISAV TM 55 autoimmune indications 55 Generx ™ 55 Elagolix 55 intra abdominal infections 55 therapeutic monoclonal antibody 55 Phase IIB 55 Thelin TM 55 Submits IND 55 rasagiline tablets 55 biologic DMARD 55 AFRS TM 55 Mycograb 55 MyVax R 55 bicifadine 55 epothilone 55 Synerx 55 Traficet EN 55 PRECISE Trial 55 Peginterferon alfa 2b 55 severe gastroparesis 55 AZILECT ® 55 non nucleoside inhibitor 55 Solazed TM 55 UVIDEM 55 Octreotide 55 Augment ™ 55 p# inhibitor 55 Supernus Pharmaceuticals 55 Paromomycin 55 Convivia TM 55 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 55 diagnostic radiopharmaceutical 55 therapeutic monoclonal antibodies 55 OTCBB CVBT 55 initiate Phase Ib 55 orally inhaled migraine 55 omega interferon 55 novel synthetic peptide 55 Mipomersen 55 SIR Spheres